Publication: 3614

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
      QxMD      Google Scholar   
Citation:
Oncogene vol 41 (2) 260-267
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
11
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
Bristol-Myers Squibb, Genentech, Pfizer  
Grants:
U10CA180821, U10CA180882, UG1CA233163, P30CA 014089  
Corr. Author:
 
Authors:
                                                           
Networks:
CA011, CA824, LAPS-MN026, LAPS-NC007, LAPS-OH007, MN022, MUSC, NC002, OH070, SCOR   
Study
Alliance-A152001
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-80405
Phases:
N/A, 3
Keywords:
Article